Abstract:Background: Genetic mutations perturb the multipotent progenitors, which results in congenital cardiovascular disease. Therefore, it is essential to decipher the pioneer factors and the regulatory pathways that govern the specification and differentiation of mesodermal progenitors and use this information to develop targeted therapies to promote cardiovascular regeneration. Etv2 as an essential transcription factor for the development of cardiac, endothelial and hematopoietic lineages. In the present study, we used ES/EB differentiation and MEF reprogramming systems, to define Etv2 as a novel pioneer factor that relaxes the closed chromatin and drives endothelial development. Results: Using the iHA-Etv2 ES cell line, we engineered a mouse that inducibly overexpresses ETV2. The bulk RNA-seq, single cell RNA-seq data and ATAC-seq experiments showed that inducing Etv2 in MEFs and ES/EBs activated the downstream endothelial marker genes and promoted the development of endothelial lineages, supporting the notion that Etv2 functioned as a master regulator to drive the endothelial lineage development in different cellular contexts. We found that similar to other known pioneer factors, Etv2 was intrinsically able to target and bind the nucleosomes, and this capability appeared to be independent of the cellular context. To further define the mechanism, we performed Etv2, Brg1 and H3K27ac ChIP-seq analyses during MEF reprogramming and ES/EB differentiation. We found that Brg1 maintains and stabilizes the binding of Etv2 on the nucleosome, and Etv2 requires Brg1 to activate downstream genes during reprograming. Conclusion: In these studies, we defined Etv2 as a novel pioneer factor that relaxed the closed chromatin and promoted the endothelial lineage in both ES/EB differentiation and MEF reprogramming. The definition of these mechanisms will enhance our understanding of cardiovascular development and regeneration and serve as a platform for therapeutic applications for patients with congenital or aging related cardiovascular diseases.

ETS transcription factors in embryonic vascular development

ETS Transcription Factors in Immune Cells and Immune-Related Diseases

Ets1-Related Protein is a Key Regulator of Vasculogenesis in Zebrafish

Transcriptional regulators of arterial and venous identity in the developing mammalian embryo

Hematopoietic Stem Cell Transcription Factors in Cardiovascular Pathology

Discovery And Characterization Of Novel Vascular And Hematopoietic Genes Downstream Of Etsrp In Zebrafish

An "unexpected" role for EMT transcription factors in hematological development and malignancy

Targeted CRISPR-Cas9 screening identifies transcription factor network controlling murine haemato-endothelial fate commitment

Identification Of Vascular And Hematopoietic Genes Downstream Of Etsrp By Deep Sequencing In Zebrafish

First blood: the endothelial origins of hematopoietic progenitors

Interplay Among Etsrp/Er71, Scl, And Alk8 Signaling Controls Endothelial And Myeloid Cell Formation

Hematopoietic Cell Formation in the Major Arteries of the Mouse Embryo

Abstract 17503: ETV2 Functions as a Pioneer Factor and Regulates the Endothelial Lineage

New insights into the endothelial origin of hematopoietic system inspired by "TIF" approaches

Transcription Factors Regulating Embryonic Development of Pulmonary Vasculature

Making Blood from the Vessel: Extrinsic and Environmental Cues Guiding the Endothelial-to-Hematopoietic Transition

The ETS transcription factor Spi2 regulates hematopoietic cell development in zebrafish

Single-cell landscapes of long non-coding RNAs in early vascular endothelial development and hemogenic specification

2010 - IDENTIFYING NECESSARY CHROMATIN STATES AND TARGETS FOR HEMOGENIC SPECIFICATION AND REPROGRAMMING

Thrombin Receptor Regulates Hematopoiesis and Endothelial-to-Hematopoietic Transition